Scholars Central

Case reportPublished 2017

Successful Treatment of Familial Mediterranean Fever with Infliximab in a Colchicine Resistant Patient

Authors: Makiko Tajika, Mai Arai, Keiko Kobayashi, Koichiro Fujimaki, Kazunaga Agematsu, Yoh Umeda

Journal of Clinical Case Reports

Volume 7 · Issue 3 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by recurrent episodes of fever and inflammation. Approximately 10% of patients are reported to be resistant or non-responsive to colchicine. We describe a case of a 30-year-old female patient with familial Mediterranean fever resistant to treatment with colchicine and lack of clinical response to Anakinra, successfully treated with Infliximab. Our case suggests that Infliximab, an anti-TNF antibody, may represent a safe and effective therapy for the treatment of colchicine-resistant FMF.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Case Reports.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Case Reports
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Makiko Tajika”
  • BylineArticles whose byline prints “Mai Arai”
  • BylineArticles whose byline prints “Keiko Kobayashi”
  • BylineArticles whose byline prints “Koichiro Fujimaki”
  • BylineArticles whose byline prints “Kazunaga Agematsu”
  • BylineArticles whose byline prints “Yoh Umeda”